ArticleOncotarget2016

Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.

Nakho Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.